1. From the Dyslipoproteinemia and Atherosclerosis Research Unit (U.551) (A.C.S., S.G., M.J.C., J.T.), National Institute for Health and Medical Research (INSERM), Paris, and the Department of Endocrinology and Metabolism (S.G., G.T.), APHP Hôpital de La Pitié-Salpetrière, France; and the Heart Institute (InCor) (A.C.S.), Zerbini Foundation, Brasilia, Brazil.